You are currently viewing our desktop site, do you want to download our app instead?
Moneyweb Android App Moneyweb iOS App Moneyweb Mobile Web App

Biovac to distribute vaccines to SA healthcare workers -letter

South Africa has a three-month plan to import, store and distribute coronavirus vaccines for frontline healthcare workers.
Andrey Rudakov/Bloomberg

South Africa has a three-month plan to import, store and distribute coronavirus vaccines for frontline healthcare workers through a contract with pharmaceutical company Biovac Institute, a letter from the National Treasury shows.

This is the first detail on how the government plans to roll out its Covid-19 vaccine plan, following concerns that the creaking public health system would not be able to manage a large-scale vaccination programme without the involvement of the private sector.

In the letter written by Director-General Dondo Mogajane to non-profit organisation Corruption Watch (CW) and provided to Reuters by CW, Treasury has given the Department of Health approval to deviate from normal procurement processes for the transportation, storage and distribution of the vaccines in the short term.

The National Treasury and spokespeople for the Department of Health did not immediately respond to requests for comment.

With around 1.37 million total cases and more than 38 000 deaths as of Thursday, South Africa is by far the African nation hardest hit by the coronavirus pandemic and is grappling with a second wave of infections driven by a new variant of the virus first identified in the country.

Cape Town-based Biovac, part-owned by the government, has been appointed for three months to provide storage and distribution services for vaccines to inoculate frontline healthcare workers, the letter showed.

“Biovac will be involved in the importation, cold chain storage and distribution of the 1.5 million doses,” Biovac CEO Morena Makhoana told Reuters.

South Africa has said it will receive 1.5 million doses of AstraZeneca’s Covid-19 shot from the Serum Institute of India (SII), spread over January and February.

Bidding process

Regarding storage and distribution of vaccines in the medium term – over a period of six months – the letter said the government is approaching Imperial Logistics’ Health Sciences unit, Denmark’s DSV Panalpina, pharmacy chain Clicks Group’s United Pharmaceutical Distributors (UPD) and Biovac in a closed bidding process.

Imperial said it was expecting the government’s formal request for quote (RFQ) for the distribution of vaccines “in the coming days”.

“Imperial will participate, following which we will await the final outcome of the RFQ process,” it said in an emailed response to Reuters.

DSV said it could not comment outside of its closed reporting period while Clicks referred questions to the Department of Health.

The Treasury’s Mogajane was responding to CW’s Executive Director David Lewis who had written to the Treasury seeking clarity regarding emergency procurement and roll-out of vaccines.

Mogajane noted that the Auditor-General would be asked at the “appropriate time” to conduct real-time audits of the vaccines procurement process.

“CW is pleased that the Auditor-General will be involved in oversight of the use of public money for vaccine procurement,” the non-profit CW said in a statement on Thursday.

South Africa aims to vaccinate 40 million people, or two-thirds of its population, by the end of 2021.


Sort by:
  • Oldest first
  • Newest first
  • Top voted

You must be signed in to comment.


According to an article in Business Live, SA are paying more than double for this vaccine from India — Oh ja — Gupta broker ne !!!

Closed bidding process means just one thing. Corruption.

No vaccine “organized” by this lot will come anywhere near me.

Anything “closed” they can keep to themselves.

I’ve just looked through Biovac’s website and they look like a good choice.

… and this is why I bought Clicks shares.

Then buy Dis-chem as well to hedge your bets

End of comments.





Follow us:

Search Articles: Advanced Search
Click a Company: